CRAASH Barcelona
CRAASH Barcelona is a Biocat’s 3-month acceleration program that helps Catalonia-based research teams and startups launch successful device, diagnostic and digital health innovations to improve health and patient care. Teams move research to market through mentoring from experts at CIMIT (Boston), on of the most experienced health accelerators in the world.
Hybrid (online & onsite)
English
3 months (several sessions from September to December 2024)
Free of charge for participants linked with the Catalan ecosystem
What will teams get?
Through CRAASH Barcelona, each team will have:
Validation
of their market and business model (in other words: “Your business makes sense”)
Pitch deck
Teams will develop their communication skills for a comprehensive pitch deck.
Investors
Each team will have the opportunity to pitch to a panel of investors.
US experts mentoring
Participants will have more than 10 hours of mentoring from experienced US experts.
European mentoring
Each team will receive more than 36 hours of mentoring from a European expert and a European investor.
Community
As a CRAASH Barcelona fellow, you will have access to a wide community of founders, key opinion leaders, mentors, industry veterans and stakeholders.
HTA Coaching
Teams will receive personalized guidance and project feedback from expert consultants and Catalan hospitals.
The Program
This phase includes:
- Customer discovery & development
- Personalized mentorship
- Masterclasses
- HTA coaching
September 2024
Teams will learn about:
- EU health ecosystem
- Fundraising
- Storytelling
October-November 2024
A high impact program
projects accelerated, with 87% survival rate
products on the market
raised and +100 new jobs created
Positive experiences
It's a demanding program but of the highest level. The GAITS methodology from CIMIT is key to the program's success. Very useful.
Any entrepreneur within digital health, medtech or biotech should consider applying for the CRAASH Barcelona program
CRAASH has helped us to connect with our customers strategically, improve the value proposition and validate our technology in the market.
- Alicia Martínez
- Flavia Wahl
- Xavier Puñet